IL7T,HNSCC

Justin Yu1, Jacob Gadwa2,3, Richard B Ross2

  • 1Department of Otolaryngology - Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.

概括

与放射疗法 (RT) 结合的介质素-7 (IL7) 通过激活 CD8+ T 细胞,有效地减少了头部和部状细胞癌 (HNSCC) 瘤的生长. 这种免疫疗法策略增强了T细胞活动,超出了典型的免疫检查点封锁.